carbocysteine has been researched along with Pulmonary Disease, Chronic Obstructive in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cañas, AP; Extremera Ortega, AM; Gomez Torrijos, E; Gonzalez Jimenez, OM; Gratacós Gómez, AR; Rodriguez, RG; Romo, JBJ | 1 |
| Adir, Y; Avdeev, S; Calverley, PMA; Cordeiro, CR; Jesenak, M; Koblížek, V; Papi, A; Petkova, D; Rogliani, P; Tarraf, H; Tzanakis, N; Ulmeanu, R; Uzaslan, E | 1 |
| Calzetta, L; Cazzola, M; Hanania, NA; Matera, MG; Rogliani, P | 1 |
| Alibašić, E; Čatić, T; Čengić, A; Hadžimuratović, A; Kapo, B; Krstović, G; Mehić, M; Skopljak, A; Trifunović, N | 1 |
| Huang, X; Xiao, Z; Yang, D; Zeng, Z | 1 |
| Calzetta, L; Cazzola, M; Matera, MG; Page, C; Puxeddu, E; Rogliani, P | 1 |
| Flore, MC; Graziani, C; Lanata, L; Palermo, P; Paone, G; Puglisi, G; Ramaccia, M; Saibene, F; Toti, S | 1 |
| Di Vincenzo, S; Ferraro, M; Gallina, S; Gerbino, S; Gjomarkaj, M; Lanata, L; Pace, E; Scafidi, V; Siena, L | 1 |
| Bocchino, M; Bruzzese, D; Esposito, A; Ponticiello, A; Sanduzzi, A; Stanziola, A; Valentino, MR | 1 |
| Chen, HZ; Cui, YY; Lu, HZ; Lu, JJ; Song, Y; Yu, P; Yu, ZH; Zhu, L | 1 |
| Albert, P; Calverley, P | 1 |
| Bai, CX; Chen, BY; Chen, FP; Chen, P; Huang, SG; Huang, YJ; Kang, J; Li, Q; Liu, CT; Luo, ZY; Qian, HP; Shi, Y; Wang, C; Wang, CZ; Wang, ZS; Yang, L; Yao, WZ; Yuan, BT; Yuan, JZ; Zheng, JP; Zhi, RC; Zhong, NS | 1 |
| Suissa, S; Waller, P | 1 |
| Aggarwal, D; Mohapatra, PR | 1 |
| Ishibashi, Y; Kameda, T; Masuda, K; Matsuzawa, S; Nogawa, H; Ogawa, A; Tsubuki, T | 1 |
| Macciò, A; Madeddu, C; Mantovani, G; Panzone, F | 1 |
| Calvert, J; Hooper, C | 1 |
| Asada, M; Deng, X; Fujino, N; Hatachi, Y; Kubo, H; Nagatomi, R; Nishimura, H; Sasaki, T; Shinya, K; Suzuki, T; Yamaya, M; Yasuda, H; Yoshida, M | 1 |
| Kang, J; Li, Y; Sun, L; Tang, L; Wang, S; Xu, Y | 1 |
| Carpagnano, GE; Di Gioia, G; Foschino-Barbaro, MP; Gramiccioni, E; Resta, O; Serviddio, G; Spanevello, A; Stefano, A | 1 |
| Inoue, D; Nakayama, K; Sasaki, H; Sasaki, T; Tomita, N; Yamaya, M; Yasuda, H; Yoshida, M | 1 |
| Mitchell, SC; Steventon, GB | 2 |
| Fukuchi, Y; Tatsumi, K | 1 |
| Barbieri, A; Chicca, M; Ciaccia, A; Daffonchio, L; Leis, M; Novellini, R; Pinamonti, S; Ravenna, F; Sostero, S; Venturoli, L | 1 |
5 review(s) available for carbocysteine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Topics: Acetylcysteine; Ambroxol; Carbocysteine; Disease Progression; Expectorants; Humans; Network Meta-Analysis; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Thioglycolates; Thiophenes | 2017 |
Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis.
Topics: Carbocysteine; Chi-Square Distribution; Disease Progression; Expectorants; Forced Expiratory Volume; Humans; Lung; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Topics: Acetylcysteine; Antioxidants; Carbocysteine; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Thioglycolates; Thiophenes; Treatment Outcome | 2019 |
Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases.
Topics: Anti-Inflammatory Agents; Antioxidants; Cachexia; Carbocysteine; Humans; Inflammation; Neoplasms; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2009 |
The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Topics: Animals; Anti-Inflammatory Agents; Carbocysteine; Clinical Trials as Topic; Drug Administration Schedule; Expectorants; Free Radical Scavengers; Humans; Oxidative Stress; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2008 |
5 trial(s) available for carbocysteine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
A PEACE-ful solution to COPD exacerbations?
Topics: Adrenal Cortex Hormones; Bronchodilator Agents; Carbocysteine; China; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2008 |
Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Carbocysteine; China; Double-Blind Method; Expectorants; Female; Humans; Lung Volume Measurements; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life | 2008 |
Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys).
Topics: Adult; Carbocysteine; Dinoprost; Exhalation; Female; Humans; Interleukin-6; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Time Factors; Treatment Outcome | 2004 |
Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease.
Topics: Aged; Anti-Infective Agents, Local; Carbocysteine; Common Cold; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Remission Induction; Treatment Outcome | 2006 |
Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Bronchodilator Agents; Carbocysteine; Common Cold; Disability Evaluation; Disease Progression; Drug Therapy, Combination; Expectorants; Forced Expiratory Volume; Humans; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Vital Capacity | 2007 |
15 other study(ies) available for carbocysteine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Maculopapular rash to S-carboxymethylcysteine-lysine (carbocisteine).
Topics: Carbocysteine; Drug Eruptions; Expectorants; Humans; Male; Middle Aged; Patch Tests; Pulmonary Disease, Chronic Obstructive | 2020 |
Use of mucolytics in COPD: A Delphi consensus study.
Topics: Acetylcysteine; Carbocysteine; Consensus; Drug Therapy, Combination; Expectorants; Female; Health Status; Humans; Internationality; Male; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires; Symptom Flare Up; Thioglycolates; Thiophenes; Treatment Outcome | 2020 |
Efficacy of carbocisteine in the treatment of chronic obstructive pulmonary disease and impact on the quality of life.
Topics: Adult; Aged; Carbocysteine; Expectorants; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life | 2017 |
A prospective study of the effects of carbocysteine lysine salt on frequency of exacerbations in COPD patients treated with or without inhaled steroids.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Bronchodilator Agents; Carbocysteine; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Glucocorticoids; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Severity of Illness Index; Symptom Flare Up; Treatment Outcome | 2019 |
Carbocysteine regulates innate immune responses and senescence processes in cigarette smoke stimulated bronchial epithelial cells.
Topics: Aging; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Bronchi; Carbocysteine; Cyclin-Dependent Kinase Inhibitor p21; Epithelial Cells; Flow Cytometry; Humans; Immunity, Innate; Interleukin-1; Interleukin-8; Neutrophils; Pulmonary Disease, Chronic Obstructive; RNA, Messenger; Signal Transduction; Smoking; Toll-Like Receptor 4 | 2013 |
Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Topics: Aged; Bronchodilator Agents; Carbocysteine; Expectorants; Female; Humans; Italy; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Smoking; Spirometry; Time Factors | 2016 |
A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model.
Topics: Animals; Carbocysteine; Cytokines; Dexamethasone; Disease Models, Animal; Down-Regulation; Drug Resistance; Expectorants; Female; Glucocorticoids; Histone Deacetylase 2; Male; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Smoking; Time Factors | 2016 |
Carbocisteine for acute exacerbations of COPD.
Topics: Aged; Carbocysteine; China; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome | 2008 |
Carbocisteine for acute exacerbations of COPD.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Carbocysteine; Chemistry, Pharmaceutical; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Carbocisteine can scavenge reactive oxygen species in vitro.
Topics: Animals; Bronchitis, Chronic; Carbocysteine; Cells, Cultured; Expectorants; Free Radical Scavengers; Humans; Lung Diseases; Oxidation-Reduction; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Wistar; Reactive Oxygen Species | 2009 |
Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells.
Topics: Aged; Animals; Carbocysteine; Cells, Cultured; Dogs; Endosomes; Epithelial Cells; Expectorants; Female; Humans; Hydrogen-Ion Concentration; Influenza A Virus, H3N2 Subtype; Influenza, Human; Interleukins; Male; Membrane Glycoproteins; NF-kappa B; Pulmonary Disease, Chronic Obstructive; Receptors, Virus; RNA, Viral; Trachea | 2010 |
The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke.
Topics: Animals; Bacterial Adhesion; Bacterial Load; Carbocysteine; Expectorants; Goblet Cells; Haemophilus Infections; Haemophilus influenzae; Male; Mucociliary Clearance; Mucus; Nicotiana; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Smoke; Smoking; Treatment Outcome | 2010 |
The sulphoxidation of S-carboxymethyl-L-cysteine in COPD.
Topics: Biotransformation; Carbocysteine; Chronotherapy; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Safrole; Treatment Outcome | 2006 |
Carbocysteine therapy in older people with chronic obstructive pulmonary disease.
Topics: Anti-Infective Agents, Local; Carbocysteine; Common Cold; Humans; Pulmonary Disease, Chronic Obstructive | 2006 |
Antioxidant activity of carbocysteine lysine salt monohydrate.
Topics: Aged; Aged, 80 and over; Antioxidants; Carbocysteine; Cells, Cultured; DNA Damage; Female; Glutathione; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive | 2001 |